Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Prostatodynia¿¡ ´ëÇÑ PhenoxybenzamineÀÇ È¿°ú The Effectiveness of Phenoxybenzamine on Prostatodynia

´ëÇѺñ´¢±â°úÇÐȸÁö 1983³â 24±Ç 5È£ p.902 ~ 906
¼Ò¼Ó »ó¼¼Á¤º¸
À̽ÂÂù/Lee SC À±Á¾º´/Yoon JB

Abstract


Sixteen prostatodynia cases entered the study on a trial of phenoxybenzamine (PBZ). We administered the PBZ with daily 10 mg dosage for 5 days (l st 5-day-course) to 16 cases, and then re-administered the PBZ (2nd 5-day-course) to the clinically recurred 5 cases. We obtained the following results. 1. After 1 st 5-day-course of PBZ, 7 cases of the 16 cases produced improvements on prostatic symptoms and urine flow rate, but recurrence was appeared in 5 cases of these 7 cases after 1-3 months of 1st 5-day-courSe of PBZ. 2. After 2nd 5-day-course of PBZ, 2 cases of these recurred 5 cases produced improvements on prostatic symptoms and urine flow rate.
3. 2 cases after 1st 5-day-course and 2 cases after 2nd 5-day-course produced improvements for about 1 year after 1 year after PBZ administration.

Conclusively, 4 cases of the 16 cases (25%) produced improvements.

From the above data, we thought that PBZ trial to prostatodynia has a relatively considerable value.

Å°¿öµå

Àü¸³¼±Åë; Æä³ì½Ãº¥ÀÚ¹Î; effectiveness; phenoxybenzamine; prostatodynia

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS